2022
Flavonoids exert potential in the management of hypertensive disorders in pregnancy
MAZURAKOVA, Alena, Lenka KOKLESOVA, Marek SAMEC, Erik KUDELA, Jana SIVAKOVA et. al.Základní údaje
Originální název
Flavonoids exert potential in the management of hypertensive disorders in pregnancy
Autoři
MAZURAKOVA, Alena, Lenka KOKLESOVA, Marek SAMEC, Erik KUDELA, Jana SIVAKOVA, Terezia PRIBULOVA, Martin Jozef PEC, Martin PEC, Martin KELLO, Dietrich BUSSELBERG, Olga GOLUBNITSCHAJA, Ludovit GASPAR, Martin CAPRNDA, Mariusz ADAMEK, Robert PROSECKÝ (203 Česká republika, domácí), Elmira EMINOVA, Denis BARANENKO, Peter KRUŽLIAK (703 Slovensko, garant, domácí), Peter KUBATKA a Kamil BIRINGER
Vydání
PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH, OXFORD, ELSEVIER SCI LTD, 2022, 2210-7789
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30201 Cardiac and Cardiovascular systems
Stát vydavatele
Velká Británie a Severní Irsko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 2.200
Kód RIV
RIV/00216224:14110/22:00128207
Organizační jednotka
Lékařská fakulta
UT WoS
000835961500002
Klíčová slova anglicky
Flavonoids; Hypertensive disorders; Pregnancy; Preeclampsia
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 11. 1. 2024 11:59, Mgr. Tereza Miškechová
Anotace
V originále
Hypertensive disorders in pregnancy represent severe complications of pregnancy, which, if not treated, can result in serious health consequences for the mother and the child. Flavonoids are bioactive secondary metabolites commonly found in fruits, vegetables, green tea, whole grains, and medicinal plants. Flavonoids exert potent protective efficacy in experimental models of hypertensive disorders in pregnancy, especially preeclampsia, demonstrated through their capacity to modulate inflammatory responses, oxidative stress, and vascular dysfunction. In addition to their potential as therapeutics, flavonoids or flavonoid-rich food could be helpful to decrease the risk of hypertensive disorders in pregnancy when included in the diet pattern before and during pregnancy. However, the clinical evaluation of the potential capacity of flavonoids in hypertensive disorders in pregnancy is insufficient. Due to promising results from experimental studies, we highlight the need for the evaluation of flavonoids also in an appropriate clinical setting, which can be, together with proper preventive strategies, helpful in the overall management of hypertensive disorders in pregnancy.